IP Library Assignment 013797/0292
Patent Assignment
Reel/Frame 013797/0292

Change of Name

Recorded: 2003-07-14 Pages: 2
Assignor
EUROGENE LIMITED
Executed: 2001-07-26
Assignee
ARK THERAPEUTICS LIMITED
1 FITZROY MEWS, LONDON, WIT 6DE, UNITED KINGDOM
Covered Property (1)
Use of Inhibitors of the Renin-Angiotensin System
Patent: 7,071,183 →
Application: 10/206,659 →
Publication: US 2002/0187939
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name May 16, 2019
From: ARK THERAPEUTICS, LTD.
To: FINVECTOR VISION THERAPIES LTD.
Reel/Frame 049198/0414 →
Change of Name May 16, 2019
From: FINVECTOR VISION THERAPIES LTD.
To: TRIZELL LTD.
Reel/Frame 049198/0498 →
Security Interest Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
Release of Security Interest Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →